Further studies such as knockdown or overexpression experiments in human airway epithelial cells should be completed to help us further understand FABP-5's roles in the human innate immune response in COPD and other chronic lung diseases presenting persistent airway bacterial infections. This evidence concerns the gene FABP5 and chronic lung disease.